Characterizing Predictors and Severity of Vasoplegia Syndrome After Heart Transplantation

Annals of Thoracic Surgery

Volumn 105, Issue 3, 2018, Pages 770-777

  Chan, Joshua L ^a   Kobashigawa, Jon A ^a   Aintablian, Tamar L ^a   Dimbil, Sadia J ^a   Perry, Paul A ^a   Patel, Jignesh K ^a   Kittleson, Michelle M ^a   Czer, Lawrence S ^a   Zarrini, Parham ^a   Velleca, Angela ^a   Rush, Jenna ^a   Arabia, Francisco A ^a   Trento, Alfredo ^a   Esmailian, Fardad ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; EPINEPHRINE; HEMOGLOBIN; NORADRENALIN; PANEL REACTIVE ANTIBODY; VASOPRESSIN; VASOCONSTRICTOR AGENT;

ACUTE GRAFT REJECTION; ADULT; ANEMIA; ANTIBODY MEDIATED REJECTION; ASSISTED CIRCULATION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; STERNOTOMY; SURVIVAL; VASOPLEGIA; AGED; FEMALE; HEART FAILURE; MORTALITY; RISK FACTOR;

ADULT; AGED; CARDIOPULMONARY BYPASS; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VASOCONSTRICTOR AGENTS; VASOPLEGIA;

EID: 85042156952     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2017.09.039     Document Type: Conference Paper

References (26)

1. Byrne, J.G., Leacche, M., Paul, S., et al. Risk factors and outcomes for “vasoplegia syndrome” following cardiac transplantation. Eur J Cardiothorac Surg 25 (2004), 327–332.
2. Ozal, E., Kuralay, E., Yildirim, V., et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg 79 (2005), 1615–1619.
3. Shanmugam, G., Vasoplegic syndrome—the role of methylene blue. Eur J Cardiothorac Surg 28 (2005), 705–710.
4. Carrel, T., Englberger, L., Mohacsi, P., Neidhart, P., Schmidli, J., Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg 15 (2000), 347–353.
5. Weis, F., Kilger, E., Beiras-Fernandez, A., et al. Association between vasopressor dependence and early outcome in patients after cardiac surgery. Anaesthesia 61 (2006), 938–942.
6. Kofidis, T., Struber, M., Wilhelmi, M., et al. Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation. J Thorac Cardiovasc Surg 122 (2001), 823–824.
7. Bozzetti, G., Ranucci, M., Grillone, G., Concomitant pulmonary hypertension and vasoplegia syndrome after heart transplant: a challenging picture. J Cardiothorac Vasc Anesth 22 (2008), 868–871.
8. Chemmalakuzhy, J., Costanzo, M.R., Meyer, P., et al. Hypotension, acidosis, and vasodilatation syndrome post-heart transplant: prognostic variables and outcomes. J Heart Lung Transplant 20 (2001), 1075–1083.
9. Fischer, G.W., Levin, M.A., Vasoplegia during cardiac surgery: current concepts and management. Semin Thorac Cardiovasc Surg 22 (2010), 140–144.
10. Patarroyo, M., Simbaqueba, C., Shrestha, K., et al. Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era. J Heart Lung Transplant 31 (2012), 282–287.
11. Argenziano, M., Chen, J.M., Choudhri, A.F., et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 116 (1998), 973–980.
12. Mekontso-Dessap, A., Houel, R., Soustelle, C., Kirsch, M., Thebert, D., Loisance, D.Y., Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 71 (2001), 1428–1432.
13. Papadopoulos, G., Sintou, E., Siminelakis, S., Koletsis, E., Baikoussis, N.G., Apostolakis, E., Perioperative infusion of low dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting—a double-blind randomized study. J Cardiothorac Surg, 5, 2010, 17.
14. Colson, P.H., Bernard, C., Struck, J., Morgenthaler, N.G., Albat, B., Guillon, G., Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration. Crit Care, 15, 2011, R255.
15. Kortekaas, K.A., Lindeman, J.H., Reinders, M.E., et al. Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery. Interact Cardiovasc Thorac Surg 17 (2013), 523–530.
16. Lee, J.K., Ing, C., Prothrombin complex concentrate and methylene blue for treatment of coagulopathy and vasoplegia in a pediatric heart transplant patient. A A Case Rep 6 (2016), 127–129.
17. Mayer, B., Brunner, F., Schmidt, K., Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45 (1993), 367–374.
18. Schulz, R., Nava, E., Moncada, S., Induction and potential biological relevance of a ca(2+)-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105 (1992), 575–580.
19. Grubb, K.J., Kennedy, J.L., Bergin, J.D., Groves, D.S., Kern, J.A., The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature. J Thorac Cardiovasc Surg 144 (2012), e113–e116.
20. Boyle, E.M., Pohlman, T.H., Johnson, M.C., Verrier, E.D., Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg 63 (1997), 277–284.
21. Downing, S.W., Edmunds, L.H., Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 54 (1992), 1236–1243.
22. Kirklin, J.K., Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 51 (1991), 529–531.
23. Miller, B.E., Levy, J.H., The inflammatory response to cardiopulmonary bypass. J Cardiothorac Vasc Anesth 11 (1997), 355–366.
24. Gillinov, A.M., Redmond, J.M., Winkelstein, J.A., et al. Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog. Ann Thorac Surg 57 (1994), 345–352.
25. Hosseinian, L., Weiner, M., Levin, M.A., Fischer, G.W., Methylene blue: magic bullet for vasoplegia?. Anesth Analg 122 (2016), 194–201.
26. Kilbridge, P.M., Mayer, J.E., Newburger, J.W., Hickey, P.R., Walsh, A.Z., Neufeld, E.J., Induction of intercellular adhesion molecule-1 and e-selectin mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 107 (1994), 1183–1192.